Novartis says Kisqali boosts survival in breast cancer patients

Novartis said on Sunday that Kisqali helped women with advanced breast cancer after menopause live longer, adding to data the Swiss company hopes will help convince doctors to choose its drug over Pfizer's blockbuster Ibrance.

from Reuters: Health News https://ift.tt/2nE2sBX
via IFTTT